Velocity-based resistance training to reduce inflammation in older adults

Dose-Response Effects of Velocity-Based Resistance Training on Anti-Inflammatory Responses in Older Adults

NA · National Taipei University · NCT07566832

This program will test whether different amounts of velocity-based resistance training can lower inflammation in adults aged 60–75 who do not regularly do resistance exercise.

Quick facts

PhaseNA
Study typeInterventional
Enrollment60 (estimated)
Ages60 Years to 75 Years
SexAll
SponsorNational Taipei University (other)
Locations1 site (Taipei)
Trial IDNCT07566832 on ClinicalTrials.gov

What this trial studies

This randomized intervention assigns older adults to low-, medium-, or high-volume velocity-based resistance training or a non-exercise control. Training groups complete a supervised 4-week resistance program emphasizing movement velocity followed by a 4-week detraining phase. Researchers will measure immune and anti-inflammatory markers before training, after training, and after detraining to determine volume-specific effects. The protocol excludes participants with obesity, chronic diseases, regular anti-inflammatory medication use, smoking, or recent musculoskeletal injury to better isolate exercise effects.

Who should consider this trial

Good fit: Ideal candidates are otherwise healthy adults aged 60–75 who have not engaged in regular resistance training (≥2 sessions/week) in the past year and can safely perform supervised resistance movements.

Not a fit: People with obesity (BMI >30 kg/m²), diabetes, hypertension, cancer, significant heart/kidney/liver disease, regular anti-inflammatory medication use, smoking or alcohol abuse, or inability to perform the exercises safely are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, the results could identify optimal training volumes to lower inflammation and help clinicians prescribe resistance exercise to support healthier aging.

How similar studies have performed: Previous studies have shown resistance training can reduce inflammatory markers in older adults, but velocity-based and volume-specific effects are less well established.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60-75 years or older
* No regular resistance training habit (defined as ≥2 sessions per week) in the past year
* No musculoskeletal injuries within the past six months

Exclusion Criteria:

* Obesity (BMI \> 30 kg/m²), diabetes, hypertension, cancer, heart, kidney, or liver disease, or any other condition that may influence study outcomes.
* Regular use of anti-inflammatory medications (e.g., NSAIDs).
* Smoking or alcohol abuse
* Inability to safely perform the prescribed resistance exercise movements
* Unable to fully comprehend the study information and instructions.

Where this trial is running

Taipei

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Aging, Inflammatory Response

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.